Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

BRD2 inhibition blocks SARS-CoV-2 infection by reducing transcription of the host cell receptor ACE2
Avi J. Samelson, Quang Tran, Rémy Robinot, et al.
Nature Cell Biology (2022) Vol. 24, Iss. 1, pp. 24-34
Open Access | Times Cited: 66

Showing 26-50 of 66 citing articles:

Multi-OMICs landscape of SARS-CoV-2-induced host responses in human lung epithelial cells
Sneha M. Pinto, Yashwanth Subbannayya, Hera Kim, et al.
iScience (2022) Vol. 26, Iss. 1, pp. 105895-105895
Open Access | Times Cited: 12
Targeted protein degradation reveals BET bromodomains as the cellular target of Hedgehog pathway inhibitor-1
Meropi Bagka, Hyeonyi Choi, Margaux Héritier, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 7
Relevance of BET Family Proteins in SARS-CoV-2 Infection
Nieves Lara-Ureña, Mario García‐Domínguez
Biomolecules (2021) Vol. 11, Iss. 8, pp. 1126-1126
Open Access | Times Cited: 13
Viral Hijacking of BET Proteins
Irene P. Chen, Mélanie Ott
Viruses (2022) Vol. 14, Iss. 10, pp. 2274-2274
Open Access | Times Cited: 9
Discovery of Alkenyl Oxindole as a Novel PROTAC Moiety for Targeted Protein Degradation via CRL4DCAF11Recruitment
Ying Wanga, Tianzi Wei, Man Zhao, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Host factors of SARS-CoV-2 in infection, pathogenesis, and long-term effects
Yu Zhang, Shihan Chen, Yan Tian, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 1
SARS-CoV-2 E protein interacts with BRD2 and BRD4 SEED domains and alters transcription in a different way than BET inhibition
Nieves Lara-Ureña, Elena Gómez-Marín, Isabel Pozuelo-Sánchez, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 1
Valuable Contributions and Lessons Learned from Proteomics and Metabolomics Studies of COVID-19
Bhaswati Chatterjee, Suman S. Thakur
Journal of Proteome Research (2024) Vol. 23, Iss. 10, pp. 4171-4187
Closed Access | Times Cited: 1
Advancements in the Development of Anti-SARS-CoV-2 Therapeutics
Junjie Huang, Qianqian Ma, Zhengding Su, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10820-10820
Open Access | Times Cited: 1
Altered ACE2 and interferon landscape in the COVID-19 microenvironment correlate with the anti-PD-1 response in solid tumors
Karthikeyan Subbarayan, Ahmed Al‐Samadi, Helene Schäfer, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 1
Mutational Landscape and Interaction of SARS-CoV-2 with Host Cellular Components
Mansi Srivastava, Dwight Hall, Okiemute Beatrice Omoru, et al.
Microorganisms (2021) Vol. 9, Iss. 9, pp. 1794-1794
Open Access | Times Cited: 12
Mutation of Basic Residues R283, R286, and K288 in the Matrix Protein of Newcastle Disease Virus Attenuates Viral Replication and Pathogenicity
Zhiqiang Duan, Haiying Shi, Jingru Xing, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 980-980
Open Access | Times Cited: 4
Differential haplotype expression in class I MHC genes during SARS-CoV-2 infection of human lung cell lines
Ronaldo da Silva Francisco, Jairo R. Temerozo, Cristina dos Santos Ferreira, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 4
Deciphering COVID-19 host transcriptomic complexity and variations for therapeutic discovery against new variants
Jing Xing, Rama Shankar, Meehyun Ko, et al.
iScience (2022) Vol. 25, Iss. 10, pp. 105068-105068
Open Access | Times Cited: 7
The CUT&RUN Blacklist of Problematic Regions of the Genome
Anna Nordin, Gianluca Zambanini, Pierfrancesco Pagella, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 6
Dual mechanism: Epigenetic inhibitor apabetalone reduces SARS-CoV-2 Delta and Omicron variant spike binding and attenuates SARS-CoV-2 RNA induced inflammation
Li Fu, Dean Gilham, Stephanie C. Stotz, et al.
International Immunopharmacology (2023) Vol. 117, pp. 109929-109929
Open Access | Times Cited: 3
Modulation of various host cellular machinery during COVID‐19 infection
Shivani Malvankar, Anjali Singh, Yogesh Kumar, et al.
Reviews in Medical Virology (2023) Vol. 33, Iss. 6
Open Access | Times Cited: 3
Histone acetylation, BET proteins, and periodontal inflammation
Nicholas P. Clayton, David Pellei, Lin Zhao
Molecular Oral Microbiology (2023) Vol. 39, Iss. 4, pp. 180-189
Closed Access | Times Cited: 3
Combining antiviral drugs with BET inhibitors is beneficial in combatting SARS‐CoV‐2 infection
Arpan Acharya, Tatiana G. Kutateladze, Siddappa N. Byrareddy
Clinical and Translational Discovery (2022) Vol. 2, Iss. 2
Open Access | Times Cited: 5
A comprehensive SARS-CoV-2-human protein-protein interactome network identifies pathobiology and host-targeting therapies for COVID-19
Yadi Zhou, Yuan Liu, Shagun Gupta, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 4
Systematic functional interrogation of SARS-CoV-2 host factors using Perturb-seq
Sara Sunshine, Andreas S. Puschnik, Joseph M. Replogle, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 4
Primate-specific BTN3A2 protects against SARS-CoV-2 infection by interacting with and reducing ACE2
Ling Xu, Dandan Yu, Min Xu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
miR-143 promotes cell proliferation, invasion and migration via directly binding to BRD2 in lens epithelial cells
You Chen
American Journal of Translational Research (2024) Vol. 16, Iss. 2, pp. 446-457
Open Access
Bromodomain and Extra-Terminal Domain Protein 2in Multiple Human Diseases
Yikang Ji, Wantao Chen, Xu Wang
Journal of Pharmacology and Experimental Therapeutics (2024) Vol. 389, Iss. 3, pp. 277-288
Open Access
A Review of the Bromodomain and Extraterminal Domain Epigenetic Reader Proteins: Function on Virus Infection and Cancer
Mengli Wu, Guiquan Guan, Hong Yin, et al.
Viruses (2024) Vol. 16, Iss. 7, pp. 1096-1096
Open Access

Scroll to top